The impact of behavioral changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users

International Journal of Epidemiology

Volumn 32, Issue 5, 2003, Pages 708-714

  Murray, John M ^a   Law, Matthew G ^b   Gao, Zhanhai ^a   Kaldor, John M ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatitis C; HIV; Injecting drug user; Mathematical model; Prevalence

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

DRUG USER; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; SOCIAL BEHAVIOR;

ARTICLE; AUSTRALIA; BEHAVIOR MODIFICATION; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG ABUSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEDICAL ASSESSMENT; NEEDLE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; HEALTH BEHAVIOR; HIGH RISK BEHAVIOR; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE;

AUSTRALIA;

AUSTRALIA; DISEASE TRANSMISSION, HORIZONTAL; HEALTH BEHAVIOR; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, STATISTICAL; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0142247597     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyg102     Document Type: Article

References (23)

1. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev 1996;18:137-48.
2. Rhodes T, Stimson GV, Crofts N, Ball A, Dehne K, Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS 1999;13(Suppl.A): S259-69.
3. Kaplan EH. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis 1989;11:289-98.
4. Greenhalgh D, Hay G. Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. IMA J Math Appl Med Biol 1997;14:11-38.
5. Peterson D, Willard K, Altmann M, Gatewood L, Davidson G. Monte Carlo simulation of HIV infection in an intravenous drug user community. J Acquir Immune Defic Syndr 1990;3:1086-95.
6. Massad E, Coutinho FA, Yang HM, De Carvalho HB, Mesquita F, Burattini MN. The basic reproduction ratio of HIV among intravenous drug users. Math Biosci 1994;123:227-47.
7. Iannelli M, Milner FA, Pugliese A, Gonzo M. The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. Math Biosci 1997;139:25-58.
8. Kretzschmar M, Wiessing LG. Modelling the spread of HIV in social networks of injecting drug users. AIDS 1998;12:801-11.
9. Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM. Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc London B Biol Sci 1991;331:171-87.
10. Mather D, Crofts N. A computer model of the spread of hepatitis C virus among injecting drug users. Eur J Epidemiol 1999;15:5-10.
11. Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust 1999;170:220-21.
12. Branch AID. Summary: NSW Health Department: HIV/AIDS Program. Sydney: New South Wales Department of Health, 1994.
13. Law MG. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group. J Gastroenterol Hepatol 1999;14:1100-07.
14. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia Annual Surveillance Report 2000. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 2000.
15. Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and hetero-sexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New Engl J Med 2000;342:921-29.
16. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia Annual Surveillance Report 1999. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 1999.
17. Henderson DK, Fahey BJ, Willy M et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990;113:740-46.
18. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 1995;23:273-77.
19. Germanaud J, Causse X, Dhumeaux D. Transmission de l'hépatite C lors de piqûres accidentelles. Evaluation du risque. (Transmission of hepatitis C by accidental needlestick injuries. Evaluation of the risk.) Presse Medicale 1994;23:1078-82.
20. Crofts N, Webb-Pulman J, Dolan K. An analysis of trends over time in social and behavioural factors related to the transmission of HIV among injecting drug users and prison inmates. Evaluation of the National HIV/AIDS Strategy 1993-1994 to 1995-1996, Technical Appendix 4. Canberra: Australian Government Printing Service, 1996.
21. Thorley A. Longitudinal studies of drug dependance. In: Busch C (ed.). Drug Problems in Britain:A Review of Ten Years. London: Academic Press, 1981.
22. English D, Holman CDJ, Milne E, Winter E, Hulse GK, Codde JP. The Quantification of Drug Caused Morbidity and Mortality in Australia. 1995 Edn. Canberra: Commonwealth Department of Human Services and Health, 1995.
23. Freeman AJ, Dore GJ, Law MG et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.